MRI-Guided Breast Biopsy
The most sensitive imaging technique for the detection and analysis of breast cancer.
Powerful and Informative
The ability of MRI to detect abnormalities or lesions in the breast is unmatched by any other imaging technique. Often used for high risk patients or to reconfirm ambiguous results from another imaging technique, MRI is seen as the most sensitive technique for detection of some of the smallest lesions or for identifying the earliest stages of breast cancer.
Making the Difficult Easier
Vacuum-assisted biopsy is often the method of choice for these very important MRI-guided breast biopsy procedures. The Mammotome Prima™ MR Dual Vacuum-Assisted Breast Biopsy System is the first ever in-room, vacuum-assisted MR breast biopsy system at the patient’s side to improve clinician coordination, communication, and patient focus. Paired with the HydroMARK™ Plus Breast Biopsy Site Marker for MR, this all in one solution provides greater confidence during MR-guided breast biopsies.1
MRI Suite of Solutions
Mammotome Prima™ MR System
The first ever in-room, vacuum-assisted MR breast biopsy system at the patient’s side to improve clinician coordination, communication, and patient focus.
HydroMARK™ Plus Breast Biopsy Site Marker
Same great benefits of the original HydroMARK™ markers, with added features designed to alleviate displacement during surgical excision, enhance visibility and ease of locating.2-4
MammoMARK® Biopsy Site Identifier
Rapid collagen expansion anchors the marker within the biopsy cavity reducing the likelihood of movement.5-7
HydroMARK™ Breast Biopsy Site Marker
Enduring exclusive hydrogel technology provides long-term ultrasound visibility in percutaneous breast biopsy procedures, including axillary lymph nodes.8
Would you like to know more about our MR products?
The Mammotome Prima™ MR system is available in the United States and Europe.
The HydroMARK™ Plus markers for MR are available in the United States.
1. HydroMARK™ Plus Device Test - PCR-000979 Summative, ES-002827 Claims Assessment
2. HydroMARK™ Device Test – PCR-000414, Summative Usability
3. HydroMARK™ Design Plan – ADD-00013 Rev G, Page 15
4. HydroMARK™ Device Test – PCR-000299, SDR0098 Vacuum Suction Testing
5. Rosen EL, Baker JA, Soo MS. Accuracy of a collagen-plug biopsy site marking device deployed after stereotactic core needle breast biopsy. AJR Am J Roentgenol. 2003 Nov;181(5):1295-9. doi: 10.2214/ajr.181.5.1811295. PMID: 14573422.
6. MammoMARK® Device Test – PRC043442 Rev B, pgs. 2, 5-6: Collagen Expansion
7. Corsi, F., Sorrentino, L., Sartani, A., Bossi, D., Amadori, R., Nebuloni, M., Truffi, M., Bonzini, M., & Foschi, D. (2015). Localization of nonpalpable breast lesions with sonographically visible clip: Optimizing tailored resection and clear margins.The American Journal of Surgery, 209(6), 950-958
8. Indication for lymph node using HydroMARK™ markers is limited to the United States and Canada with other country registrations pending.